Two Additional Distribution Partnerships Will Target Thousands of Additional Colorado Retail Stores Strong Pilot Results…
Boca Raton, FL, Sept. 07, 2022 (GLOBE NEWSWIRE) — INmune Bio (NASDAQ: INMB), a clinical-…
FORT LEE, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a…
SOLANA BEACH, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical…
BERKELEY HEIGHTS, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Top Executives Bring Expertise to Further Fuel Company Growth Tamara Elias, MD Tamara Elias, MD,…
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today…
FLORHAM PARK, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a…
CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
ISELIN, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial…
CUPERTINO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
SAN CARLOS, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Apexigen, Inc. (NASDAQ: APGN) a clinical-stage…
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
Proof-of-Concept Established in Phase 2 Trial of TGCT, with Positive Efficacy Results Across Multiple Clinical…
CONSHOHOCKEN, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage…
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) a biotechnology company…
Industry veteran strengthens Recce’s Board of Directors with significant operating experience SYDNEY, Australia, Sept. 07,…
CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
– First patient was enrolled as part of a two-stage Phase 2 study evaluating Ashvattha’s…
WALTHAM, Mass. and SHANGHAI, China, Sept. 07, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global…